Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Osteochondroma”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Not applicableStudy completedNCT00474448
What this trial is testing

The Health-Related Quality of Life in Patients With Hereditary Multiple Exostoses

Who this might be right for
Exostoses, Multiple Hereditary
University of British Columbia 200
Not applicableTemporarily pausedNCT00474331
What this trial is testing

Gene Mutations and Orthopaedic Symptoms Correlation of Multiple Hereditary Exostoses: Multicentre Project

Who this might be right for
Exostoses, Multiple Hereditary
University of British Columbia 2,000
Not applicableLooking for participantsNCT06703736
What this trial is testing

Functional and Morphological Characterization of Multiple Osteochondromas Disorder

Who this might be right for
Hereditary Multiple Osteochondromas
Istituto Ortopedico Rizzoli 60
Not applicableStudy completedNCT06397443
What this trial is testing

Ready to Sail: Evaluating Sailing's Feasibility as Ergotherapy

Who this might be right for
Multiple OsteochondromaOllier DiseaseOsteogenesis Imperfecta
Istituto Ortopedico Rizzoli 8
Large-scale testing (Phase 3)Study completedNCT00568178
What this trial is testing

An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))

Who this might be right for
Proteinuria
Organon and Co 306
Testing effectiveness (Phase 2)Ended earlyNCT00767000
What this trial is testing

Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 813
Not applicableStudy completedNCT03557567
What this trial is testing

NGS Strategy Effectiveness in Molecular Diagnosis

Who this might be right for
Multiple OsteochondromaOsteogenesis Imperfecta
Istituto Ortopedico Rizzoli 400
Not applicableStudy completedNCT04844697
What this trial is testing

Resilience and Coping in a Rare Skeletal Disease Population to Face Coronavirus (COVID-19) Outbreak Distress: a Longitudinal Study

Who this might be right for
Multiple OsteochondromaOsteogenesis ImperfectaOllier Disease+1 more
Istituto Ortopedico Rizzoli 15
Not applicableEnded earlyNCT00473850
What this trial is testing

Establishing the Genetic Profile of Multiple Hereditary Exostoses (HME) in Families of BC

Who this might be right for
Exostoses, Multiple Hereditary
University of British Columbia 2,000
Not applicableLooking for participantsNCT04133285
What this trial is testing

Registry of Multiple Osteochondromas

Who this might be right for
Multiple Osteochondromas
Luca Sangiorgi 10,000
Not applicableStudy completedNCT05914298
What this trial is testing

Height, Ulnar Length and Forearm Function in Multiple Hereditary Exostoses

Who this might be right for
Exostoses, Multiple Hereditary
Istituto Ortopedico Rizzoli 408
Early research (Phase 1)Study completedNCT00771472
What this trial is testing

Vorinostat (MK-0683) Phase I Study in Cutaneous T-Cell Lymphoma (CTCL) Patients (MK-0683-089 EXT1)

Who this might be right for
Lymphoma
Merck Sharp & Dohme LLC 10
Testing effectiveness (Phase 2)Ended earlyNCT03442985
What this trial is testing

An Efficacy and Safety Study of Palovarotene for the Treatment of MO

Who this might be right for
Exostoses, Multiple Hereditary
Clementia Pharmaceuticals Inc. 193
Early research (Phase 1)Study completedNCT00479232
What this trial is testing

Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)

Who this might be right for
Leukemia, Myelocytic, Acute Myelodysplastic SyndromesMyelodysplastic Syndromes
Merck Sharp & Dohme LLC 71